Virtu KCG Holdings’s Virtus Biotech ETF BBP Stock Holding History

Virtu KCG Holdings’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$627K	Buy	15,864 +10,112	+176%	+$378K	0.02%	937
2017 Q1	$217K	Sell	5,752 -16,263	-74%	-$596K	0.01%	2329
2016 Q4	$721K	Buy	22,015 +3,054	+16%	+$100K	0.02%	1079
2016 Q3	$633K	Buy	+18,961	New	+$586K	0.02%	1153
2016 Q2	–	Sell	-22,734	Closed	-$561K	–	2940
2016 Q1	$561K	Buy	22,734 +13,232	+139%	+$322K	0.02%	1074
2015 Q4	$293K	Sell	9,502 -14,037	-60%	-$425K	0.01%	2184
2015 Q3	$650K	Buy	+23,539	New	+$794K	0.01%	1263

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtu KCG Holdings's BBP Position: Q2 2017 in Review

Virtu KCG Holdings increased its Virtus Biotech ETF (BBP) stake by 176% in Q2 2017, buying an estimated $378K and bringing the position to 15,864 shares worth $627K. The position accounts for 0.02% of the portfolio, ranked #937.

Virtu KCG Holdings first reported a position in BBP in Q3 2015 and has held it in 7 quarters since. The position peaked at $721K in Q4 2016. 19 funds tracked by Wall St. Rank hold BBP as of Q2 2017.

Virtu KCG Holdings held 15,864 shares of Virtus Biotech ETF worth $627K as of Q2 2017.
Virtu KCG Holdings bought 10,112 Virtus Biotech ETF shares in Q2 2017, an estimated $378K.
Virtus Biotech ETF made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #937 holding.
Virtu KCG Holdings first reported a position in Virtus Biotech ETF in Q3 2015 and has held it in 7 quarters since.
Virtu KCG Holdings's Virtus Biotech ETF position peaked at $721K in Q4 2016.
19 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.